glp 1 and glp 2 drugs Best Med #2: GLP-1 Receptor Agonists — vim Performance Medicine Practice Nursing - GLP-1 receptor
Description
Clinical efficacyweight loss of 5% to 15%remains consistent between compounded and brand versions
Classification, diagnosis, screening and prevention (Update 2019)
Nakamaru Y, Akahoshi F, Iijima H, Hisanaga N, Kume T
Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis
There are multiple amylins in phase II trials, including Amycretin (another dual amylin/GLP-1 agonist, Novo Nordisk) and Eloralintide (a single-target amylin analogue, Eli Lilly)
